Hubei Kailong Chemical Group Co., Ltd. Logo

Hubei Kailong Chemical Group Co., Ltd.

002783.SZ

(2.0)
Stock Price

8,38 CNY

1.82% ROA

7.18% ROE

32.26x PER

Market Cap.

4.142.929.375,00 CNY

126.95% DER

1.18% Yield

3.48% NPM

Hubei Kailong Chemical Group Co., Ltd. Stock Analysis

Hubei Kailong Chemical Group Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Hubei Kailong Chemical Group Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

2 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 ROE

The stock's ROE falls within an average range (9.27%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (2.14%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (2.45x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

7 DER

The stock is burdened with a heavy load of debt (170%), making it financially unstable and potentially risky for investors.

8 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-314), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Hubei Kailong Chemical Group Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Hubei Kailong Chemical Group Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Hubei Kailong Chemical Group Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Hubei Kailong Chemical Group Co., Ltd. Revenue
Year Revenue Growth
2008 392.882.494
2009 477.137.808 17.66%
2010 570.076.765 16.3%
2011 785.417.368 27.42%
2012 918.987.486 14.53%
2013 895.938.604 -2.57%
2014 884.275.005 -1.32%
2015 890.604.850 0.71%
2016 953.713.189 6.62%
2017 1.358.950.370 29.82%
2018 1.865.209.867 27.14%
2019 1.891.371.944 1.38%
2020 2.010.941.155 5.95%
2021 2.741.290.851 26.64%
2022 3.405.945.794 19.51%
2023 4.010.207.269 15.07%
2023 3.778.757.833 -6.13%
2024 3.808.617.604 0.78%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Hubei Kailong Chemical Group Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 16.743.006 100%
2013 29.560.574 43.36%
2014 24.107.449 -22.62%
2015 26.469.124 8.92%
2016 30.080.453 12.01%
2017 41.444.137 27.42%
2018 40.032.232 -3.53%
2019 50.858.757 21.29%
2020 29.972.582 -69.68%
2021 45.486.397 34.11%
2022 66.935.964 32.04%
2023 93.568.890 28.46%
2023 80.709.059 -15.93%
2024 123.371.248 34.58%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Hubei Kailong Chemical Group Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 34.350.646
2009 59.343.696 42.12%
2010 63.009.600 5.82%
2011 66.496.546 5.24%
2012 15.205.191 -337.33%
2013 16.699.154 8.95%
2014 16.527.943 -1.04%
2015 15.077.377 -9.62%
2016 22.203.193 32.09%
2017 38.454.234 42.26%
2018 39.650.378 3.02%
2019 44.957.591 11.8%
2020 49.217.292 8.65%
2021 67.339.410 26.91%
2022 64.999.810 -3.6%
2023 911.856.293 92.87%
2023 162.082.728 -462.59%
2024 -182.749.925 188.69%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Hubei Kailong Chemical Group Co., Ltd. EBITDA
Year EBITDA Growth
2008 57.654.724
2009 118.352.783 51.29%
2010 116.360.654 -1.71%
2011 148.866.516 21.84%
2012 217.055.871 31.42%
2013 228.896.600 5.17%
2014 231.180.982 0.99%
2015 214.250.404 -7.9%
2016 229.512.899 6.65%
2017 285.738.132 19.68%
2018 365.992.235 21.93%
2019 432.219.720 15.32%
2020 465.327.939 7.12%
2021 402.177.388 -15.7%
2022 647.569.980 37.89%
2023 531.751.633 -21.78%
2023 810.309.478 34.38%
2024 765.911.320 -5.8%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Hubei Kailong Chemical Group Co., Ltd. Gross Profit
Year Gross Profit Growth
2008 132.071.064
2009 237.525.974 44.4%
2010 259.025.355 8.3%
2011 312.112.823 17.01%
2012 335.522.253 6.98%
2013 362.075.448 7.33%
2014 359.783.627 -0.64%
2015 336.210.708 -7.01%
2016 398.030.886 15.53%
2017 503.669.775 20.97%
2018 630.262.815 20.09%
2019 692.215.885 8.95%
2020 554.769.616 -24.78%
2021 627.203.523 11.55%
2022 814.459.320 22.99%
2023 1.114.478.999 26.92%
2023 1.030.670.654 -8.13%
2024 970.582.168 -6.19%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Hubei Kailong Chemical Group Co., Ltd. Net Profit
Year Net Profit Growth
2008 52.156.144
2009 95.303.384 45.27%
2010 94.033.790 -1.35%
2011 106.004.985 11.29%
2012 105.347.419 -0.62%
2013 121.612.228 13.37%
2014 107.152.992 -13.49%
2015 97.593.761 -9.79%
2016 108.779.750 10.28%
2017 115.013.172 5.42%
2018 81.763.854 -40.67%
2019 113.113.542 27.72%
2020 93.565.292 -20.89%
2021 -486.434.623 119.23%
2022 133.331.555 464.83%
2023 230.789.079 42.23%
2023 175.350.930 -31.62%
2024 153.211.280 -14.45%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Hubei Kailong Chemical Group Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 -1 100%
2022 0 0%
2023 1 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Hubei Kailong Chemical Group Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2008 -1.563.181
2009 -88.309.025 98.23%
2010 -154.669.498 42.9%
2011 -128.648.723 -20.23%
2012 113.363.426 213.48%
2013 110.502.554 -2.59%
2014 59.551.698 -85.56%
2015 150.727.510 60.49%
2016 103.206.178 -46.05%
2017 -8.959.747 1251.89%
2018 -90.836.406 90.14%
2019 -327.949.752 72.3%
2020 -186.639.573 -75.71%
2021 -249.024.379 25.05%
2022 28.201.188 983.03%
2023 4.570.378 -517.04%
2023 12.852.300 64.44%
2024 90.381.683 85.78%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Hubei Kailong Chemical Group Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2008 59.207.678
2009 0 0%
2010 0 0%
2011 0 0%
2012 181.121.860 100%
2013 164.622.624 -10.02%
2014 115.879.489 -42.06%
2015 197.436.353 41.31%
2016 145.939.929 -35.29%
2017 156.409.131 6.69%
2018 236.062.276 33.74%
2019 281.364.398 16.1%
2020 98.510.126 -185.62%
2021 9.665.681 -919.17%
2022 262.720.115 96.32%
2023 488.934.555 46.27%
2023 80.183.551 -509.77%
2024 131.697.722 39.12%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Hubei Kailong Chemical Group Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2008 60.770.859
2009 88.309.025 31.18%
2010 154.669.498 42.9%
2011 128.648.723 -20.23%
2012 67.758.433 -89.86%
2013 54.120.070 -25.2%
2014 56.327.790 3.92%
2015 46.708.842 -20.59%
2016 42.733.750 -9.3%
2017 165.368.878 74.16%
2018 326.898.682 49.41%
2019 609.314.150 46.35%
2020 285.149.699 -113.68%
2021 258.690.060 -10.23%
2022 234.518.926 -10.31%
2023 484.364.177 51.58%
2023 67.331.251 -619.37%
2024 41.316.039 -62.97%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Hubei Kailong Chemical Group Co., Ltd. Equity
Year Equity Growth
2008 275.791.127
2009 359.243.631 23.23%
2010 425.715.061 15.61%
2011 510.337.462 16.58%
2012 596.271.082 14.41%
2013 688.818.954 13.44%
2014 767.512.070 10.25%
2015 1.353.220.527 43.28%
2016 1.559.104.376 13.21%
2017 1.657.684.290 5.95%
2018 1.939.707.500 14.54%
2019 2.226.550.322 12.88%
2020 2.637.162.376 15.57%
2021 2.081.150.312 -26.72%
2022 2.255.596.773 7.73%
2023 2.502.985.516 9.88%
2023 2.472.935.286 -1.22%
2024 3.341.530.330 25.99%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Hubei Kailong Chemical Group Co., Ltd. Assets
Year Assets Growth
2008 507.345.189
2009 612.256.048 17.14%
2010 778.159.831 21.32%
2011 954.394.231 18.47%
2012 1.039.264.292 8.17%
2013 1.145.879.134 9.3%
2014 1.195.330.074 4.14%
2015 1.751.475.685 31.75%
2016 1.897.563.871 7.7%
2017 2.392.302.989 20.68%
2018 3.810.615.709 37.22%
2019 4.411.074.545 13.61%
2020 6.698.110.596 34.14%
2021 6.809.728.251 1.64%
2022 7.463.057.067 8.75%
2023 7.463.096.757 0%
2023 7.528.081.821 0.86%
2024 8.121.510.573 7.31%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Hubei Kailong Chemical Group Co., Ltd. Liabilities
Year Liabilities Growth
2008 231.554.062
2009 253.012.417 8.48%
2010 352.444.770 28.21%
2011 444.056.767 20.63%
2012 442.993.209 -0.24%
2013 457.060.179 3.08%
2014 427.818.003 -6.84%
2015 398.255.156 -7.42%
2016 338.459.493 -17.67%
2017 734.618.698 53.93%
2018 1.870.908.208 60.73%
2019 2.184.524.223 14.36%
2020 4.060.948.218 46.21%
2021 4.728.577.937 14.12%
2022 5.207.460.293 9.2%
2023 4.960.111.240 -4.99%
2023 5.055.146.535 1.88%
2024 4.712.448.713 -7.27%

Hubei Kailong Chemical Group Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
7.54
Net Income per Share
0.26
Price to Earning Ratio
32.26x
Price To Sales Ratio
1.12x
POCF Ratio
7.51
PFCF Ratio
12.26
Price to Book Ratio
1.71
EV to Sales
1.77
EV Over EBITDA
13.26
EV to Operating CashFlow
11.87
EV to FreeCashFlow
19.38
Earnings Yield
0.03
FreeCashFlow Yield
0.08
Market Cap
4,14 Bil.
Enterprise Value
6,55 Bil.
Graham Number
5.4
Graham NetNet
-4.82

Income Statement Metrics

Net Income per Share
0.26
Income Quality
4.29
ROE
0.07
Return On Assets
0.02
Return On Capital Employed
0.08
Net Income per EBT
0.48
EBT Per Ebit
0.74
Ebit per Revenue
0.1
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.05
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.26
Operating Profit Margin
0.1
Pretax Profit Margin
0.07
Net Profit Margin
0.03

Dividends

Dividend Yield
0.01
Dividend Yield %
1.18
Payout Ratio
1.57
Dividend Per Share
0.1

Operating Metrics

Operating Cashflow per Share
1.12
Free CashFlow per Share
0.69
Capex to Operating CashFlow
0.39
Capex to Revenue
0.06
Capex to Depreciation
0.62
Return on Invested Capital
0.05
Return on Tangible Assets
0.02
Days Sales Outstanding
119.21
Days Payables Outstanding
98.88
Days of Inventory on Hand
51.59
Receivables Turnover
3.06
Payables Turnover
3.69
Inventory Turnover
7.07
Capex per Share
0.44

Balance Sheet

Cash per Share
2,56
Book Value per Share
6,95
Tangible Book Value per Share
4.78
Shareholders Equity per Share
4.94
Interest Debt per Share
6.52
Debt to Equity
1.27
Debt to Assets
0.38
Net Debt to EBITDA
4.87
Current Ratio
0.82
Tangible Asset Value
2,35 Bil.
Net Current Asset Value
-1,72 Bil.
Invested Capital
3779324438
Working Capital
-0,67 Bil.
Intangibles to Total Assets
0.13
Average Receivables
1,10 Bil.
Average Payables
0,89 Bil.
Average Inventory
408163714
Debt to Market Cap
0.74

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Hubei Kailong Chemical Group Co., Ltd. Dividends
Year Dividends Growth
2016 1
2017 1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2023 0 0%
2024 0 0%

Hubei Kailong Chemical Group Co., Ltd. Profile

About Hubei Kailong Chemical Group Co., Ltd.

Hubei Kailong Chemical Group Co., Ltd. engages in the production and sale of explosive materials in China. The company offers civil explosive; nano-calcium carbonate; nitro compound fertilizers; ammonium nitrate; and paper plastic packaging products. It also engages in the engineering blasting business. Hubei Kailong Chemical Group Co., Ltd. was founded in 1967 and is based in Jingmen, China.

CEO
Mr. Shihua Luo
Employee
3.731
Address
20th Quankou Road
Jingmen, 448032

Hubei Kailong Chemical Group Co., Ltd. Executives & BODs

Hubei Kailong Chemical Group Co., Ltd. Executives & BODs
# Name Age
1 Mr. Jie Sun
Deputy GM & Secretary of the Board of Directors
70
2 Ms. Ming Chun Shu
Deputy General Manager
70
3 Mr. Song Hua Li
Deputy General Manager
70
4 Mr. Zhe Liu
Deputy GM & Director
70
5 Mr. Hong Teng
Deputy General Manager
70
6 Mr. Yong Zhang
Chief Financial Officer & Deputy GM
70
7 Mr. Xue Jun Han
Deputy General Manager
70
8 Mr. Feng Shao
Executive Deputy GM & Director
70
9 Mr. Shihua Luo
Vice Chairman & GM
70
10 Mr. Weidong Lu
Deputy GM & Director
70

Hubei Kailong Chemical Group Co., Ltd. Competitors